Cycurion, Inc.
For the period ended Jun 30, 2025. Filed Aug 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 13, 2025
CYCU$2.470.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| For the Six Months Ended | ||
|---|---|---|
| June 30, 2025 | June 30, 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(15,538,900) | $(6,381) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock based compensation | 10,534,777 | 10,000 |
| Amortization of debt discount | 213,036 | - |
| Depreciation of property and equipment | 3,489 | 4,394 |
| Amortization of software development costs | 17,083 | - |
| Loss on debt settlement, net | 766,330 | - |
| Finance expense | 100,000 | - |
| Changes in assets and liabilities: | ||
| Accounts receivable, net and other receivables | (1,478,433) | (1,267,911) |
| Prepaid expenses and other current assets | 45,204 | 16,050 |
| Accounts payable and accrued liabilities | (965,708) | 393,435 |
| Net cash used in operating activities | (6,303,122) | (850,413) |
| Cash flows from investing activities: | ||
| Cash acquired on acquisition of subsidiary | 34,983 | - |
| Issuance of promissory notes | - | (354,000) |
| Purchase of plant and equipment | (174,000) | (238,000) |
| Cash withdrawn from Trust Account in connection with redemption | 1,001,216 | - |
| Release of Trust Account to Company’s bank account | 833,324 | - |
| Net cash provided by/(used in) investing activities | 1,695,523 | (592,000) |
| Cash flows from financing activities: | ||
| Proceeds from exercise of warrants | 3,664,671 | - |
| Redemption of common stock subject to redemption | (1,001,216) | - |
| Proceeds from private placement | - | 1,000,000 |
| Proceeds from capital raise | 265,504 | - |
| Net proceeds from line of credit | (12,900) | 39,181 |
| Repayment of bank borrowings | (155,114) | (6,503) |
| Proceeds from convertible notes payable | 2,376,500 | - |
| Proceeds from notes payable | 513,200 | - |
| Repayments of notes payable | (70,000) | - |
| Net cash provided by financing activities | 5,580,645 | 1,032,678 |
| Net increase/(decrease) in cash and cash equivalents | 973,046 | (409,735) |
| Cash and cash equivalents, beginning of period | 40,790 | 607,869 |
| Cash and cash equivalents, end of period | $1,013,836 | $198,134 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.